Idelalisib is prescribed to treat patients with cancer of the blood or bone marrow such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, and follicular B-cell non-Hodgkin lymphoma (FL) whose cancer has returned after treating with some anti-cancer medicines.
Imatinib is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, acute lymphoblastic leukemia(cancer of the white blood cells), gastrointestinal stromal tumors (tumors of the gastrointestinal tract and other cancers.
Inotuzumab ozogamicin is a CD 22 - directed antibody-drug conjugate which is prescribed to treat adult patients suffering from relapsed or refractory B-cell precursor acute lymphoblastic leukemia, a type of blood cancer.
Insoluble Prussian Blue is a dark blue pigment, prescribed for internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination in certain patients.
Interferon Alfa 2A is prescribed for hairy cell leukemia (blood cancer), AIDS-related Kaposi's sarcoma (type of cancer that develops in connective tissues), recurrent or metastatic renal cell carcinoma (kidney cancer) and chronic myelogenous leukemia (cancer of white blood cells), hepatitis C, non-Hodgin’s lymphoma.
Ioxilan is a nonionic, water soluble, triiodinated x-ray contrast agent, prescribed for cerebral arteriography, excretory urography and Contrast Enhanced Computed Tomographic (CECT) imaging of the head and body.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer